{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["FOXO3a", "NF\u2010\u03baB", "Suaeda vermiculata", "apoptosis", "hepatocellular carcinoma", "p\u2010AKT"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38506534", "DateCompleted": {"Year": "2024", "Month": "05", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1002/tox.24217"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "20"}], "Journal": {"ISSN": "1522-7278", "JournalIssue": {"Volume": "39", "Issue": "6", "PubDate": {"Year": "2024", "Month": "Jun"}}, "Title": "Environmental toxicology", "ISOAbbreviation": "Environ Toxicol"}, "ArticleTitle": "Targeting the PI3K/pAKT/mTOR/NF-\u03baB/FOXO3a signaling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk.", "Pagination": {"StartPage": "3666", "EndPage": "3678", "MedlinePgn": "3666-3678"}, "Abstract": {"AbstractText": ["Liver malignancy is well recognized as a prominent health concern, with numerous treatment options available. Natural products are considered a renewable source, providing inspiring chemical moieties that could be used for cancer treatment. Suaeda vermiculata Forssk has traditionally been employed for management of hepatic conditions, including liver inflammation, and liver cirrhosis, as well as to improve general liver function. The findings of our earlier study demonstrated encouraging in vivo hepatoprotective benefits against liver injury generated by paracetamol and carbon tetrachloride. Additionally, Suaeda vermiculata Forssk exhibited cytotoxic activities in vitro against Hep-G2 cell lines and cell lines resistant to doxorubicin. The present investigation aimed to examine the potential in vivo hepatoprotective efficacy of Suaeda vermiculata Forssk extract (SVE) against hepatocellular carcinoma induced by diethylnitrosamine (DENA) in rats. The potential involvement of the PI3K/AKT/mTOR/NF-\u03baB pathway was addressed. Sixty adult male albino rats were allocated into five groups randomly (n\u2009=\u200910). First group received a buffer, whereas second group received SVE only, third group received DENA only, and fourth and fifth groups received high and low doses of SVE, respectively, in the presence of DENA. Liver toxicity and tumor markers (HGFR, p-AKT, PI3K, mTOR, NF-\u03baB, FOXO3a), apoptosis markers, and histopathological changes were analyzed. The current results demonstrated that SVE inhibited PI3K/AKT/mTOR/NF-\u03baB pathway as well as increased expression of apoptotic parameters and FOXO3a levels, which were deteriorated by DENA treatment. Furthermore, SVE improved liver toxicity markers and histopathological changes induced by DENA administration. This study provided evidence for the conventional hepatoprotective properties attributed to SV and investigated the underlying mechanism by which its extract, SVE, could potentially serve as a novel option for hepatocellular carcinoma (HCC) treatment derived from a natural source."], "CopyrightInformation": "\u00a9 2024 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Egypt."}], "LastName": "Abdel-Bakky", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Egypt."}], "LastName": "Mohammed", "ForeName": "Hamdoon A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Egypt."}], "LastName": "Mahmoud", "ForeName": "Nesreen I", "Initials": "NI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Egypt."}], "LastName": "Amin", "ForeName": "Elham", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, College of Medicine, Qassim University, Saudi Arabia."}], "LastName": "Alsharidah", "ForeName": "Mansour", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, College of Medicine and Medical Sciences, Qassim University, Unaizah, Qassim, Saudi Arabia."}], "LastName": "Al Rugaie", "ForeName": "Osamah", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Egypt."}], "LastName": "Ewees", "ForeName": "Mohamed G", "Initials": "MG"}], "GrantList": [{"GrantID": "QU-IF-1-2-2", "Agency": "Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Toxicol", "NlmUniqueID": "100885357", "ISSNLinking": "1520-4081"}, "ChemicalList": [{"RegistryNumber": "3IQ78TTX1A", "NameOfSubstance": "Diethylnitrosamine"}, {"RegistryNumber": "0", "NameOfSubstance": "Forkhead Box Protein O3"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "EC 2.7.1.-", "NameOfSubstance": "Phosphatidylinositol 3-Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["drug therapy", "chemically induced", "pathology"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["chemistry"], "DescriptorName": "Chenopodiaceae"}, {"QualifierName": ["toxicity"], "DescriptorName": "Diethylnitrosamine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Forkhead Box Protein O3"}, {"QualifierName": ["drug effects", "pathology", "metabolism"], "DescriptorName": "Liver"}, {"QualifierName": ["drug therapy", "chemically induced", "pathology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "TOR Serine-Threonine Kinases"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ozakyol A. Global epidemiology of hepatocellular carcinoma (HCC epidemiology). J Gastrointest Cancer. 2017;48(3):238\u2010240."}, {"Citation": "Brar TS, Hilgenfeldt E, Soldevila\u2010Pico C. Etiology and pathogenesis of hepatocellular carcinoma. Precision Molecular Pathology of Liver Cancer. Springer; 2018:1\u201015."}, {"Citation": "Kim D, Li AA, Perumpail BJ, et al. Changing trends in etiology\u2010based and ethnicity\u2010based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69(3):1064\u20101074."}, {"Citation": "Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P. Hepatocellular carcinoma in 2021: an exhaustive update. Cureus. 2021;13(11):1\u201019."}, {"Citation": "Ryoo BY, Palmer DH, Park SR, et al. Efficacy and safety results from a phase 2, randomized, double\u2010blind study of enzalutamide versus placebo in advanced hepatocellular carcinoma. Clin Drug Investig. 2021;41(9):795\u2010808."}, {"Citation": "Kudo M. Impaired response to immunotherapy in non\u2010alcoholic steatohepatitis\u2010related hepatocellular carcinoma? Liver Cancer. 2021;10(4):289\u2010295."}, {"Citation": "Li W, Deng R, Liu S, Wang K, Sun J. Hepatitis B virus\u2010related hepatocellular carcinoma in the era of antiviral therapy: the emerging role of non\u2010viral risk factors. Liver Int. 2020;40(10):2316\u20102325."}, {"Citation": "Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular carcinoma (HCC) in Egypt: a comprehensive overview. J Egypt Natl Canc Inst. 2020;32(1):1\u201011."}, {"Citation": "Akula SM, Abrams SL, Steelman LS, et al. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opin Ther Targets. 2019;23(11):915\u2010929."}, {"Citation": "Kearns JD, Basak S, Werner SL, Huang CS, Hoffmann A. I\u03baB\u03b5 provides negative feedback to control NF\u2010\u03baB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol. 2006;173(5):659\u2010664."}, {"Citation": "Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer\u2010related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073\u20101081."}, {"Citation": "Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805\u2010820."}, {"Citation": "Liu T, Zhang L, Joo D, Sun SC. NF\u2010\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):1\u20109."}, {"Citation": "Fan Y, Mao R, Yang J. NF\u2010\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013;4(3):176\u2010185."}, {"Citation": "Luo JL, Kamata H, Karin M. IKK/NF\u2010\u03baB signaling: balancing life and death\u2013a new approach to cancer therapy. J Clin Invest. 2005;115(10):2625\u20102632."}, {"Citation": "Schmidt D, Textor B, Pein OT, et al. Critical role for NF\u2010\u03baB\u2010induced JunB in VEGF regulation and tumor angiogenesis. EMBO J. 2007;26(3):710\u2010719."}, {"Citation": "Ringelhan M, Pfister D, O'Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222\u2010232."}, {"Citation": "Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKK\u03b2 couples hepatocyte death to cytokine\u2010driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell. 2005;121(7):977\u2010990."}, {"Citation": "Ren F, Zhang W, Lu S, Ren H, Guo Y. NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF\u2010\u03baB signaling pathways. Oncol Lett. 2020;19(1):813\u2010823."}, {"Citation": "Yang H, Li H, Lu S, Shan S, Guo Y. Fuzheng Jiedu decoction induces apoptosis and enhances cisplatin efficacy in ovarian cancer cells in vitro and in vivo through inhibiting the PI3K/AKT/mTOR/NF\u2010\u03baB signaling pathway. Biomed Res Int. 2022;2022(1):1\u201018."}, {"Citation": "Helmy M, Ghoneim AI, Katary MA, Elmahdy RK. The synergistic anti\u2010proliferative effect of the combination of diosmin and BEZ\u2010235 (dactolisib) on the HCT\u2010116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF\u2010\u03baB axis. Mol Biol Rep. 2020;47(3):2217\u20102230."}, {"Citation": "El\u2010Hanboshy SM, Helmy MW, Abd\u2010Alhaseeb MM. Catalpol synergistically potentiates the anti\u2010tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF\u2010\u03baB and VEGF/VEGFR2 signaling pathways. Mol Biol Rep. 2021;48(11):7233\u20107242."}, {"Citation": "Quan Z, Yang Y, Zheng H, et al. Clinical implications of the interaction between PD\u20101/PD\u2010L1 and PI3K/AKT/mTOR pathway in progression and treatment of non\u2010small cell lung cancer. J Cancer. 2022;13(13):3434\u20103443."}, {"Citation": "Pengyu S, Lijuan Z. Natural \u03b2\u2010elemene: advances in targeting cancer through different molecular pathways. North Am J Acad Res. 2018;1(4):27."}, {"Citation": "Ahmad B, Khan S, Liu Y, et al. Molecular mechanisms of anticancer activities of puerarin. Cancer Manag Res. 2020;12:79\u201090."}, {"Citation": "Mohammed HA, Emwas AH, Khan RA. Salt\u2010tolerant plants, halophytes, as renewable natural resources for cancer prevention and treatment: roles of phenolics and flavonoids in immunomodulation and suppression of oxidative stress towards cancer management. Int J Mol Sci. 2023;24(6):5171."}, {"Citation": "Mohammed SAA, Khan RA, El\u2010Readi MZ, et al. Suaeda vermiculata aqueous\u2010ethanolic extract\u2010based mitigation of ccl4\u2010induced hepatotoxicity in rats, and hepg\u20102 and hepg\u20102/adr cell\u2010lines\u2010based cytotoxicity evaluations. Plants. 2020;9(10):1291."}, {"Citation": "Zhang TT, Yang L, Jiang JG. Effects of thonningianin a in natural foods on apoptosis and cell cycle arrest of HepG\u20102 human hepatocellular carcinoma cells. Food Funct. 2015;6(8):2588\u20102597."}, {"Citation": "Wang X, Wei Y, Yuan S, Liu G, Zhang YLJ, Wang W. Potential anticancer activity of litchi fruit pericarp extract against hepatocellular carcinoma in vitro and in vivo. Cancer Lett. 2006;239(1):144\u2010150."}, {"Citation": "Fan Y, Liu J, Liu D, et al. NSCA\u20101\u2014a novel N\u2010substituted coumalamide derivative\u2014increases Adriamycin sensitivity in HepG2/adriamycin cells through modulating Akt/GSK\u20103\u03b2 signaling and p53\u2010dependant apoptotic pathway. Environ Toxicol Pharmacol. 2017;49:1\u20107."}, {"Citation": "Sefidanzadeh S, Ziarati P, Motamed SM. Chemical composition of Suaeda vermiculata seeds grown in hormozgan in the south of Iran. Biosci Biotechnol Res Asia. 2015;12(3):1923\u20101929."}, {"Citation": "Mohammed HA, Al\u2010Omar MS, Aly MSA, Hegazy MM. Essential oil Constituents and biological activities of the halophytic plants, Suaeda Vermiculata Forssk and Salsola Cyclophylla Bakera growing in Saudi Arabia. J Essent Oil\u2010Bearing Plants. 2019;22(1):82\u201093. doi:10.1080/0972060X.2019.1574611"}, {"Citation": "Diab TA, Donia T, Saad\u2010Allah KM. Characterization, antioxidant, and cytotoxic effects of some Egyptian wild plant extracts. Beni\u2010Suef Univ J Basic Appl Sci. 2021;10(1):1\u201013."}, {"Citation": "Mohammed H, Al\u2010Mahmoud S, Arfeen M, et al. LC\u2010MS Profiled Chemical Constituents, Molecular Modeling, and In vitro Bioactivity Evaluations of Suaeda vermiculata Extracts as Anti\u2010Hepatocellular Carcinoma Preparation: Assessment of the Constituents' Role, and Receptor Docking Feasibility Based Activi. Arab J Chem. 2022;15:103950."}, {"Citation": "Mohammed SAA, Eldeeb HM, Mohammed HA, et al. Roles of Suaeda vermiculata aqueous\u2010ethanolic extract, its subsequent fractions, and the isolated compounds in hepatoprotection against paracetamol\u2010induced toxicity as compared to silymarin. Oxidative Med Cell Longev. 2021;2021(1):1\u201010."}, {"Citation": "Al\u2010Omar MS, Sajid MSM, Alnasyan NS, et al. The halophytic plant, Suaeda vermiculata Forssk extracts reduce the inflamed paw edema and exert potential antimicrobial activity. Pak J Bot. 2021;53(1):351\u2010356."}, {"Citation": "Othman SS, Ali SM. Antimicrobial and histological data effect of Silybum marianum and Suaeda vermiculata against doxorubicin induced toxicity in male rats. Asian Pacific J Cancer Prev APJCP. 2021;22(6):1761\u20101766."}, {"Citation": "Mohammed HA. The valuable impacts of halophytic genus Suaeda mathsemicolon nutritional, Chemical, and biological values. Med Chem (Los Angeles). 2020;16:1044\u20101057. doi:10.2174/1573406416666200224115004"}, {"Citation": "Gill SS, Tuteja N. Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants. Plant Physiol Biochem. 2010;48(12):909\u2010930."}, {"Citation": "Amin E, Musa A. Evaluation of the antioxidant, total phenolics and total flavonoids of suaeda species collected in Al Jouf area. European J Med Plants. 2016;17:1\u20106."}, {"Citation": "Cybulska I, Brudecki G, Alassali A, Thomsen M, Brown JJ. Phytochemical composition of some common coastal halophytes of The United Arab Emirates. Emirates J Food Agric. 2014;26(12):1046\u20101057."}, {"Citation": "Fathy AH, Bashandy MA, Bashandy SAE, Mansour AM, Elsadek B. Sequential analysis and staging of a diethylnitrosamine\u2010induced hepatocellular carcinoma in male Wistar albino rat model. Can J Physiol Pharmacol. 2017;95(12):1462\u20101472."}, {"Citation": "Mohammed HA. Behavioral evaluation of the effects of aqueous and ethanol extracts of suaeda vermiculata forssk on rats. Cent Nerv Syst Agents Med Chem (Formerly Curr Med Chem Nerv Syst Agents). 2020;20(2):122\u2010127."}, {"Citation": "Abdel\u2010Bakky MS, Hammad MA, Walker LA, Ashfaq MK. Loss of retinoic acid receptor (RAR) and retinoid X receptor (RXR) contribute to liver toxicity in MCT/LPS co\u2010treated mice model. Planta Med. 2010;76(5):P100."}, {"Citation": "Suvarna KS, Layton C, Bancroft JD. Bancroft's theory and practice of histological techniques. Elsevier Health Sciences; 2018."}, {"Citation": "Sroor FM, Basyouni WM, Aly HF, Younis EA, Mahrous KF, Haroun AA. Biochemical and histopathological studies of sulfonylurea derivative as a new chemotherapeutic agent against liver cancer in free\u2010and nano\u2010coated forms. Appl Biol Chem. 2022;65(1):68."}, {"Citation": "El\u2010Fattah A, Eslam E, Saber S, et al. AKT\u2010AMPK\u03b1\u2010mTOR\u2010dependent HIF\u20101\u03b1 activation is a new therapeutic target for cancer treatment: a novel approach to repositioning the antidiabetic drug sitagliptin for the management of hepatocellular carcinoma. Front Pharmacol. 2022;12:720173."}, {"Citation": "Phondani PC, Bhatt A, Elsarrag E, Horr YA. Ethnobotanical magnitude towards sustainable utilization of wild foliage in Arabian Desert. J Tradit Complement Med. 2016;6(3):209\u2010218."}, {"Citation": "Al\u2010Tohamy R, Ali SS, Saad\u2010Allah K, et al. Phytochemical analysis and assessment of antioxidant and antimicrobial activities of some medicinal plant species from Egyptian flora. J Appl Biomed. 2018;16(4):289\u2010300."}, {"Citation": "Ravikumar S, Gnanadesigan M, Inbaneson SJ, Kalaiarasi A. Hepatoprotective and antioxidant properties of Suaeda maritima (L.) Dumort ethanolic extract on concanavalin\u2010a induced hepatotoxicity in rats. 2011."}, {"Citation": "Elsharabasy FS, Metwally NS, Mahmoud AH, Soliman MS, Youness ER, Farrag AH. Phytoconstituents and hepatoprotective effect of Suaeda monoica Forssk and Suaeda pruinosa Lange. Biomed Pharmacol J. 2019;12(1):117\u2010129."}, {"Citation": "Guo L, Bai Y, Ji S, Ma H. MicroRNA\u201098 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k\u2010Ras/Raf/MEK/ERK signaling pathway. Int J Oncol. 2019;54(3):807\u2010820."}, {"Citation": "Lu G, Wu X, Zhao Z, et al. MicroRNA\u2010126 regulates the phosphatidylinositol\u20103 kinase (PI3K)/protein kinase B (AKT) pathway in SLK cells in vitro and the expression of its pathway members in Kaposi's sarcoma tissue. Medicine (Baltimore). 2018;97(35):e11855."}, {"Citation": "Chen S, Wu J, Jiao K, et al. MicroRNA\u2010495\u20103p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer. Cell Death Dis. 2018;9(11):1\u201012."}, {"Citation": "Garc\u00eda\u2010Vilas JA, Medina M\u00c1. Updates on the hepatocyte growth factor/c\u2010met axis in hepatocellular carcinoma and its therapeutic implications. World J Gastroenterol. 2018;24(33):3695\u20103708."}, {"Citation": "To CT, Tsao MS. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers. Oncol. Rep. 1998;5:1013\u20101037."}, {"Citation": "Pelicci G, Giordano S, Zhen Z, et al. The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene. 1995;10(8):1631\u20101638."}, {"Citation": "Koundouros N, Poulogiannis G. Phosphoinositide 3\u2010kinase/Akt signaling and redox metabolism in cancer. Front Oncol. 2018;8:160."}, {"Citation": "Dong J, Zhai B, Sun W, Hu F, Cheng H, Xu J. Activation of phosphatidylinositol 3\u2010kinase/AKT/snail signaling pathway contributes to epithelial\u2010mesenchymal transition\u2010induced multi\u2010drug resistance to sorafenib in hepatocellular carcinoma cells. PLoS One. 2017;12(9):e0185088."}, {"Citation": "Xing S, Yu W, Zhang X, et al. Isoviolanthin extracted from Dendrobium officinale reverses TGF\u2010\u03b21\u2010mediated epithelial\u2013mesenchymal transition in hepatocellular carcinoma cells via deactivating the TGF\u2010\u03b2/Smad and PI3K/Akt/mTOR signaling pathways. Int J Mol Sci. 2018;19(6):1556."}, {"Citation": "Scheau C, Badarau IA, Costache R, et al. The role of matrix metalloproteinases in the epithelial\u2010mesenchymal transition of hepatocellular carcinoma. Anal Cell Pathol. 2019;2019:1\u201010."}, {"Citation": "Sun EJ, Wankell M, Palamuthusingam P, McFarlane C, Hebbard L. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Biomedicines. 2021;9(11):1\u201020. doi:10.3390/biomedicines9111639"}, {"Citation": "Vasjari L, Bresan S, Biskup C, Pai G, Rubio I. Ras signals principally via Erk in G1 but cooperates with PI3K/Akt for cyclin D induction and S\u2010phase entry. Cell Cycle. 2019;18(2):204\u2010225."}, {"Citation": "Song S, Ying J, Zhang Y, et al. High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma. Oncol Lett. 2020;19(4):3181\u20103188. doi:10.3892/ol.2020.11430"}, {"Citation": "Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W. FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci. 2017;13(7):815\u2010827."}, {"Citation": "Ding L, Cao J, Lin W, et al. The roles of cyclin\u2010dependent kinases in cell\u2010cycle progression and therapeutic strategies in human breast cancer. Int J Mol Sci. 2020;21(6):1960."}, {"Citation": "Chen J. The cell\u2010cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med. 2016;6(3):1\u201015. doi:10.1101/cshperspect.a026104"}, {"Citation": "Maetani Y, Asano S, Mizokami A, et al. Expression of PRIP, a phosphatidylinositol 4, 5\u2010bisphosphate binding protein, attenuates PI3K/AKT signaling and suppresses tumor growth in a xenograft mouse model. Biochem Biophys Res Commun. 2021;552:106\u2010113."}, {"Citation": "Gordon MA, D'Amato NC, Gu H, et al. Synergy between androgen receptor antagonism and inhibition of mTOR and HER2 in breast cancer. Mol Cancer Ther. 2017;16(7):1389\u20101400."}, {"Citation": "Rocha G d G, Oliveira RR, Kaplan MAC, Gattass CR. 3\u03b2\u2010acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity. Eur J Pharmacol. 2014;741:140\u2010149. doi:10.1016/j.ejphar.2014.07.054"}, {"Citation": "Goan YG, Wu WT, Liu CI, Neoh CA, Wu YJ. Involvement of mitochondrial dysfunction, endoplasmic reticulum stress, and the PI3K/AKT/mTOR pathway in nobiletin\u2010induced apoptosis of human bladder cancer cells. Molecules. 2019;24(16):1\u201014. doi:10.3390/molecules24162881"}, {"Citation": "Dutta S, Mahalanobish S, Saha S, Ghosh S, Sil PC. Natural products: an upcoming therapeutic approach to cancer. Food Chem Toxicol. 2019;128:240\u2010255."}, {"Citation": "Ting LQ, Jun QM, Li YS, et al. Alpha\u2010Fetoprotein Regulates the Expression of Immune\u2010Related Proteins through the NF\u2010\u03baB (P65) Pathway in Hepatocellular Carcinoma Cells. Li D, ed. J Oncol. 2020;2020:9327512. doi:10.1155/2020/9327512"}, {"Citation": "Wang S, Zhu M, Wang Q, et al. Alpha\u2010fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling. Cell Death Dis. 2018;9(10):1027. doi:10.1038/s41419\u2010018\u20101036\u20105"}, {"Citation": "Taniguchi K, Karin M. NF\u2010\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309\u2010324."}], "Title": "REFERENCES"}], "History": [{"Year": "2024", "Month": "1", "Day": "3"}, {"Year": "2023", "Month": "10", "Day": "11"}, {"Year": "2024", "Month": "3", "Day": "4"}, {"Year": "2024", "Month": "5", "Day": "15", "Hour": "12", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "20", "Hour": "12", "Minute": "45"}, {"Year": "2024", "Month": "3", "Day": "20", "Hour": "9", "Minute": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38506534", "10.1002/tox.24217"]}}]}